Daiichi Sankyo

Showing of 1 - 20 from 43 results
Daiichi Sankyo - Total results - 43
Daiichi Sankyo case: SC holds former Ranbaxy promoters Malvinder, Shivinder Singh guilty of contempt of court
Business

Daiichi Sankyo case: SC holds former Ranbaxy promoters Malvinder, Shivinder Singh guilty of contempt of court

The Supreme Court on Friday held former Ranbaxy promoters Malvinder Singh and Shivinder Singh guilty of contempt of court for violating its order asking them not to divest their shares in Fortis Healthcare Limited

Daiichi-Ranbaxy case: Radha Soami chief claims in Delhi High Court don't owe money to Singh brothers
Business

Daiichi-Ranbaxy case: Radha Soami chief claims in Delhi High Court don't owe money to Singh brothers

Radha Soami Satsang Beas (RSSB) head Gurinder Singh Dhillon and his family members on Friday approached the Delhi High Court saying they do not owe any money to RHC Holdings Pvt Ltd, promoted by Malvinder and Shivinder Singh

Fortis acquisition: IHH Healthcare says it 'understands concerns' of minority shareholders over delay in open offer
Business

Fortis acquisition: IHH Healthcare says it 'understands concerns' of minority shareholders over delay in open offer

Malaysian firm IHH Healthcare on Friday said it "understands the concerns" of the Fortis Healthcare's minority shareholders over the delay in the open offer but stressed that it would proceed with the offer only when the stay is lifted by the Supreme Court

Ranbaxy promoters Malvinder, Shivinder Singh diverted funds despite order to maintain stakes, Daiichi Sankyo tells SC
Business

Ranbaxy promoters Malvinder, Shivinder Singh diverted funds despite order to maintain stakes, Daiichi Sankyo tells SC

The Supreme Court had earlier expressed displeasure at the replies of Malvinder and Shivinder to its directive to submit a plan for paying Rs 4,000 crore to Daiichi Sankyo, as awarded by a Singapore tribunal.

Sun Pharma's senior executive, wife settle insider trading case with SEBI
Business

Sun Pharma's senior executive, wife settle insider trading case with SEBI

Sun Pharma group's senior executive Abhay Arvind Gandhi and his wife Kiran have settled with SEBI a case related to insider trading in shares of Ranbaxy Laboratories in 2014

Miffed at replies of ex-Ranbaxy promoters, Supreme Court to hear Daiichi's contempt plea against them
Business

Miffed at replies of ex-Ranbaxy promoters, Supreme Court to hear Daiichi's contempt plea against them

Miffed at replies of former Ranbaxy promoters Malvinder and Shivinder Singh to its directive to submit a plan for paying Rs 4,000 crore to Daiichi Sankyo, as awarded by a Singapore tribunal, the Supreme Court on Friday threatened to send them to jail if found that they have violated the apex court's order

SC asks Malvinder Singh and Shivinder Singh to submit concrete plan for paying Rs 3,500 cr to Daiichi Sankyo
Business

SC asks Malvinder Singh and Shivinder Singh to submit concrete plan for paying Rs 3,500 cr to Daiichi Sankyo

The Supreme Court on Thursday asked former Ranbaxy promoters Malvinder Singh and Shivinder Singh to submit a concrete plan for paying Rs 3,500 crore to Daiichi Sankyo as directed by a Singapore tribunal

SC asks Ranbaxy’s former promoters Singh brothers how they plan to pay Rs 3,500 cr to Daiichi Sankyo
Business

SC asks Ranbaxy’s former promoters Singh brothers how they plan to pay Rs 3,500 cr to Daiichi Sankyo

The SC, on 14 December last year, had ordered status quo with regard to the sale of controlling stakes of Fortis Healthcare.

Malvinder Singh alleges spiritual leader Gurinder Singh Dhillon used money from Ranbaxy stake sale to buy properties
Business

Malvinder Singh alleges spiritual leader Gurinder Singh Dhillon used money from Ranbaxy stake sale to buy properties

Malvinder Singh, in his complaint filed with the Economic Offences Wing in February, said that RHC Holding Pvt. Ltd, made loans worth Rs 5,482 crore to Dhillon’s family members

Singh brothers' feud is a wake-up call for corporate governance in dysfunctional family-run companies
Business

Singh brothers' feud is a wake-up call for corporate governance in dysfunctional family-run companies

The Singh brothers have lost control of two listed companies — Fortis Healthcare and Religare Enterprises — in less than a decade.

Malvinder Singh files criminal complaint against brother Shivinder Singh, spiritual leader for financial fraud, death threat
Business

Malvinder Singh files criminal complaint against brother Shivinder Singh, spiritual leader for financial fraud, death threat

The relationship between the Singh brothers, erstwhile promoters of Fortis Healthcare, went sour after allegations of fund diversion from the healthcare chain emerged.

SEBI asks Fortis Healthcare, Fortis Hospitals to recover Rs 403 crore from Singh brothers, seven others
India

SEBI asks Fortis Healthcare, Fortis Hospitals to recover Rs 403 crore from Singh brothers, seven others

The fresh order comes after the two companies made representation to the markets regulator.

Religare approaches Corporate Ministry with complaint against Singh brothers, ex-chairman Sunil Godhwani
Business

Religare approaches Corporate Ministry with complaint against Singh brothers, ex-chairman Sunil Godhwani

Earlier on Wednesday, Religare Finvest lodged a criminal complaint with the Economic Offences Wing (EOW) of the Delhi Police against the Singh brothers.

Unable to proceed with Fortis open offer for time being as SC order puts on hold further stake sale: IHH Healthcare
Business

Unable to proceed with Fortis open offer for time being as SC order puts on hold further stake sale: IHH Healthcare

Malaysia's IHH Healthcare on Monday said it will not be able to proceed with the open offer for Fortis Healthcare for the time being, following the Supreme Court order to put on hold sale of controlling stake in the Indian hospital chain.

NCLT dismisses HDFC plea for initiating insolvency proceedings against RHC Holding
Business

NCLT dismisses HDFC plea for initiating insolvency proceedings against RHC Holding

The National Company Law Tribunal (NCLT) on Thursday dismissed the plea of HDFC Ltd to initiate insolvency proceedings against RHC Holding, a non-banking financial company promoted by Singh brothers -- Malvinder Mohan Singh and Shivinder Mohan Singh.

Daiichi Sankyo moves NCLT to stay insolvency plea against RHC Holding initiated by HDFC Bank
Business

Daiichi Sankyo moves NCLT to stay insolvency plea against RHC Holding initiated by HDFC Bank

Daiichi Sankyo, which has filed an intervention application in the insolvency plea filed by HDFC Bank, said they have a decree to recover money against RHC Holding.

Shivinder Mohan Singh withdraws petition against brother Malvinder; market reacts favourably with Religare Enterprises trading up 6%
Business

Shivinder Mohan Singh withdraws petition against brother Malvinder; market reacts favourably with Religare Enterprises trading up 6%

Shivinder had filed a lawsuit last week against older brother Malvinder and former chief of financial services firm Religare Enterprises Sunil Godhwani

Daiichi writes to ED: Singh brothers of Ranbaxy fame formed companies of ‘dubious nature’ to siphon off money
Business

Daiichi writes to ED: Singh brothers of Ranbaxy fame formed companies of ‘dubious nature’ to siphon off money

Daaichi is awaiting to get an arbitration award of Rs 3,500 from Singh brothers who according to the company did not reveal full details of Ranbaxy at the time of selling it to Daiichi.

Fortis Healthcare shares soar 24.5% to Rs 157.05 on merger buzz
Business

Fortis Healthcare shares soar 24.5% to Rs 157.05 on merger buzz

Shares of Fortis Healthcare jumped 24.5 percent on Friday amid reports that Manipal hospital, backed by TPG, is in advanced talks to merge the company with itself.

Fortis founders alleged to have siphoned off Rs 500 cr out of hospital, co denies report
Business

Fortis founders alleged to have siphoned off Rs 500 cr out of hospital, co denies report

Fortis founders Malvinder Singh and his brother Shivinder Singh have been alleged to have siphoned off around Rs 500 crore or $78 million out of the publicly-traded hospital, Fortis Hospitals Ltd. (FHSL), without board approval a year ago, Bloomberg reported, quoting sources.